Mulmit

Summit Therapeutics Inc.Summit Therapeutics Inc.

SMMT Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2024-12-310-225,998,000-221,315,000-0.31
2023-12-310-609,650,000-614,928,000-0.99
2022-12-31705,000-72,089,000-78,782,000-0.41
2021-12-311,809,000-86,186,000-88,602,000-0.67
2020-12-31860,000-53,193,000-52,697,000-0.76

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-06-12Zanganeh MahkamCo-Chief Executive Officer3,810,000
2026-06-12DUGGAN ROBERT WCo-Chief Executive Officer3,810,000
2026-06-04Soni Manmeet SinghCOO and CFO25,000
2026-06-04Soni Manmeet SinghCOO and CFO25,000
2026-06-04Zanganeh MahkamCo-Chief Executive Officer100,000
2026-06-04DUGGAN ROBERT WCo-Chief Executive Officer100,000
2026-01-08Anand BhaskarChief Accounting Officer30,000
2026-01-02Xia Yu35,000
2026-01-02Cesano Alessandra35,000
2026-01-02Cesano Alessandra3,219
2026-01-02Clark Kenneth A35,000
2026-01-02Clark Kenneth A17,796

8-K events

FiledItems
2026-09-03Other events · Financial statements and exhibits
2026-08-26Other events · Financial statements and exhibits
2026-08-05Other events · Financial statements and exhibits
2026-07-23Entry into a material agreement · Financial statements and exhibits
2026-07-23Results of operations · Regulation FD disclosure · Financial statements and exhibits
2026-07-22Other events · Financial statements and exhibits
2026-06-12Submission of matters to a vote
2026-06-11Regulation FD disclosure
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…